Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/EBITDA
-29.12 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical Inc's enterprise value is $15,895.5 Mil. Biomarin Pharmaceutical Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2016 was $-545.8 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/EBITDA ratio for today is -29.12.

BMRN' s EV/EBITDA Range Over the Past 10 Years
Min: -25504   Max: 1532.3
Current: -29.12

-25504
1532.3

During the past 13 years, the highest EV/EBITDA Ratio of Biomarin Pharmaceutical Inc was 1532.30. The lowest was -25504.00. And the median was -74.85.

BMRN's EV/EBITDA is ranked lower than
99.99% of the 264 Companies
in the Global Biotechnology industry.

( Industry Median: 20.40 vs. BMRN: -29.12 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Biomarin Pharmaceutical Inc's stock price is $96.22. Biomarin Pharmaceutical Inc's earnings per share for the trailing twelve months (TTM) ended in Jun. 2016 was $-3.30. Therefore, Biomarin Pharmaceutical Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Biomarin Pharmaceutical Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=15895.508/-545.814
=-29.12

Biomarin Pharmaceutical Inc's current Enterprise Value is $15,895.5 Mil.
Biomarin Pharmaceutical Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2016 was -65.117 (Sep. 2015 ) + 96.929 (Dec. 2015 ) + -59.039 (Mar. 2016 ) + -518.587 (Jun. 2016 ) = $-545.8 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=96.22/-3.3
=

Biomarin Pharmaceutical Inc's share price for today is $96.22.
Biomarin Pharmaceutical Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2016 was -0.6 (Sep. 2015 ) + 0.44 (Dec. 2015 ) + -0.53 (Mar. 2016 ) + -2.61 (Jun. 2016 ) = $-3.30.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -101.90-326.1726.4558.82180.64-23,974.95-94.71-81.24-219.12-217.17

Biomarin Pharmaceutical Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
ev2ebitda -87.25-81.97-207.79-219.12-209.15-151.60-74.04-217.17-164.12-23.58
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK